Understanding the safety and effectiveness of vaccines is a priority for both public health officials and vaccine manufacturers. This common goal provides opportunities to share knowledge and resources and to create synergies and alignment.

Public-private partnerships provide an effective and transparent way for interested parties to work together to achieve common goals. The governance model we aim to build for DRIVE will enable partners to fulfil their missions and obligations sustainably and ensure studies are scientifically robust and independently conducted and reviewed.

In DRIVE, we follow the Code of Conduct as described by the IMI funded ADVANCE consortium. ADVANCE accelerates the development of a vaccine benefit-risk collaboration in Europe.

See Work Package Descriptions here
See Partner abbreviations here

DRIVE influenza vaccinne effectiveness research consortium